Evaluation on HBeAg conversion time when treating chronic hepatitis B patients with combination of lamivudine and traditional Chinese medicine

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Volumn 29, Issue 12, 2008, Pages 1243-1247

  Bai, Song Lin ^a   Hu, Xiao Yu ^a   Zhong, Sen ^a  

^a CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B(E) ANTIGEN; HERBACEOUS AGENT; LAMIVUDINE;

ARTICLE; BLOOD; CHINESE MEDICINE; DRUG COMBINATION; HEPATITIS B; HUMAN; IMMUNOLOGY; META ANALYSIS; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; TIME; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROLOGIC TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77449123279     PISSN: 02546450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)